Please enable JavaScript to continue using this application.

Compare $CYRX vs $DNA | Chartloom

Compare

$CYRX vs $DNA

Cryoport Inc · Ginkgo Bioworks Holdings Inc

CYRX

Cryoport Inc

DNA

Ginkgo Bioworks Holdings Inc

Compare $CYRX vs $DNA

Comparing Cryoport Inc and Ginkgo Bioworks Holdings Inc

CYRXCryoport Inc

DNAGinkgo Bioworks Holdings Inc

CYRXCryoport Inc

Market cap

$874M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.18x

Rev growth (TTM)

-8.0%

YTD performance

81.5%

52W performance

72.5%

FCF yield

-2.4%

DNAGinkgo Bioworks Holdings Inc

Market cap

$810M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-51.5%

YTD performance

49.4%

52W performance

-19.2%

FCF yield

-21.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CYRX

DNA

Detailed metrics comparison

CYRX

Cryoport Inc

DNA

Ginkgo Bioworks Holdings Inc

Market Cap

CYRX$874M

DNA$810M

Enterprise Value

CYRX$793M

DNA$726M

Price

CYRX$17.35

DNA$13.00

P/E Ratio

CYRXN/A

DNAN/A

P/S Ratio

CYRX4.69x

DNA7.24x

EV/Sales

CYRX4.25x

DNA6.49x

EV/EBITDA

CYRX1,004.45x

DNA0.00x

P/B Ratio

CYRX1.80x

DNA1.98x

P/FCF Ratio

CYRXN/A

DNAN/A

EV/FCF

CYRX-37.15x

DNA-4.15x

PEG Ratio

CYRXN/A

DNAN/A

Forward P/E (NTM)

CYRXN/A

DNAN/A

Forward P/S (NTM)

CYRX4.18x

DNAN/A

Revenue (TTM)

CYRX$186M

DNA$112M

Revenue Growth (YoY)

CYRX-8.0%

DNA-51.5%

Forward Rev Growth

CYRX8.9%

DNA13.4%

Gross Margin (TTM)

CYRX47.1%

DNA77.7%

Operating Margin (TTM)

CYRX0.0%

DNA0.0%

EBITDA Margin (TTM)

CYRX-7.4%

DNA-210.7%

Net Margin (TTM)

CYRX-24.3%

DNA-260.0%

FCF Margin (TTM)

CYRX-11.4%

DNA-156.3%

Net Income (TTM)

CYRX$-45M

DNA$-291M

FCF (TTM)

CYRX$-21M

DNA$-175M

EPS (TTM)

CYRX-$0.90

DNA-$4.68

ROE (TTM)

CYRX-747.0%

DNA-6021.0%

ROA (TTM)

CYRX-489.0%

DNA-2685.0%

ROIC (TTM)

CYRX-543.0%

DNA-6021.0%

Cash

CYRX$269M

DNA$85M

Debt

CYRX$188M

DNA$0

Net Cash/Debt

CYRX$81M

DNA$85M

Current Ratio (TTM)

CYRX2.08x

DNA4.57x

Quick Ratio (TTM)

CYRX1.96x

DNA4.37x

Debt/Equity (TTM)

CYRX0.38x

DNA0.00x

Debt/Assets (TTM)

CYRX0.0%

DNA0.0%

Interest Coverage (TTM)

CYRXN/A

DNAN/A

Net Debt/EBITDA (TTM)

CYRX0.00x

DNA0.00x

Beta

CYRX1.88

DNA1.69

52W Performance

CYRX72.5%

DNA-19.2%

YTD Performance

CYRX81.5%

DNA49.4%

% from 52W High

CYRX-5.5%

DNA-28.6%

% from 52W Low

CYRX128.0%

DNA142.1%

Asset Turnover (TTM)

CYRX0.24x

DNA0.10x

FCF Yield (TTM)

CYRX-2.4%

DNA-21.6%

Earnings Yield (TTM)

CYRX-5.2%

DNA-35.9%

Dividend Yield (TTM)

CYRXN/A

DNAN/A

Rule of 40

CYRX-19.5

DNA-207.8

EV/GP/RG

CYRX0.63

DNA0.42

Ticker research

View CYRX research View DNA research

Metric	CYRX Cryoport Inc	DNA Ginkgo Bioworks Holdings Inc
Market & Valuation
Market Cap	$874M	$810M
Enterprise Value	$793M	$726M
Price	$17.35	$13.00
P/E Ratio	N/A	N/A
P/S Ratio	4.69x	7.24x
EV/Sales	4.25x	6.49x
EV/EBITDA	1,004.45x	0.00x
P/B Ratio	1.80x	1.98x
P/FCF Ratio	N/A	N/A
EV/FCF	-37.15x	-4.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.18x	N/A
Revenue & Growth
Revenue (TTM)	$186M	$112M
Revenue Growth (YoY)	-8.0%	-51.5%
Forward Rev Growth	8.9%	13.4%
Profitability
Gross Margin (TTM)	47.1%	77.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7.4%	-210.7%
Net Margin (TTM)	-24.3%	-260.0%
FCF Margin (TTM)	-11.4%	-156.3%
Net Income (TTM)	$-45M	$-291M
FCF (TTM)	$-21M	$-175M
EPS (TTM)	-$0.90	-$4.68
ROE (TTM)	-747.0%	-6021.0%
ROA (TTM)	-489.0%	-2685.0%
ROIC (TTM)	-543.0%	-6021.0%
Financial Health
Cash	$269M	$85M
Debt	$188M	$0
Net Cash/Debt	$81M	$85M
Current Ratio (TTM)	2.08x	4.57x
Quick Ratio (TTM)	1.96x	4.37x
Debt/Equity (TTM)	0.38x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	1.69
52W Performance	72.5%	-19.2%
YTD Performance	81.5%	49.4%
% from 52W High	-5.5%	-28.6%
% from 52W Low	128.0%	142.1%
Efficiency & Yields
Asset Turnover (TTM)	0.24x	0.10x
FCF Yield (TTM)	-2.4%	-21.6%
Earnings Yield (TTM)	-5.2%	-35.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-19.5	-207.8
EV/GP/RG	0.63	0.42
Ticker research	View CYRX research	View DNA research

Valuation

P/S Ratio

CYRX

4.69x

DNA

7.24x

EV/FCF

CYRX

-37.15x

DNA

-4.15x

Growth & revenue

Revenue Growth TTM

CYRX

-8.0%

DNA

-51.5%

Forward Revenue Growth

DNA

13.4%

CYRX

8.9%

Profitability & performance

Gross Margin

DNA

77.7%

CYRX

47.1%

ROE

CYRX

-747.0%

DNA

-6021.0%

FCF Yield %

CYRX

-2.4%

DNA

-21.6%

52-Week Performance

CYRX

72.5%

DNA

-19.2%

Detailed metrics comparison

CYRX

Cryoport Inc

DNA

Ginkgo Bioworks Holdings Inc

Market Cap

CYRX$874M

DNA$810M

Enterprise Value

CYRX$793M

DNA$726M

Price

CYRX$17.35

DNA$13.00

P/E Ratio

CYRXN/A

DNAN/A

P/S Ratio

CYRX4.69x

DNA7.24x

EV/Sales

CYRX4.25x

DNA6.49x

EV/EBITDA

CYRX1,004.45x

DNA0.00x

P/B Ratio

CYRX1.80x

DNA1.98x

P/FCF Ratio

CYRXN/A

DNAN/A

EV/FCF

CYRX-37.15x

DNA-4.15x

PEG Ratio

CYRXN/A

DNAN/A

Forward P/E (NTM)

CYRXN/A

DNAN/A

Forward P/S (NTM)

CYRX4.18x

DNAN/A

Revenue (TTM)

CYRX$186M

DNA$112M

Revenue Growth (YoY)

CYRX-8.0%

DNA-51.5%

Forward Rev Growth

CYRX8.9%

DNA13.4%

Gross Margin (TTM)

CYRX47.1%

DNA77.7%

Operating Margin (TTM)

CYRX0.0%

DNA0.0%

EBITDA Margin (TTM)

CYRX-7.4%

DNA-210.7%

Net Margin (TTM)

CYRX-24.3%

DNA-260.0%

FCF Margin (TTM)

CYRX-11.4%

DNA-156.3%

Net Income (TTM)

CYRX$-45M

DNA$-291M

FCF (TTM)

CYRX$-21M

DNA$-175M

EPS (TTM)

CYRX-$0.90

DNA-$4.68

ROE (TTM)

CYRX-747.0%

DNA-6021.0%

ROA (TTM)

CYRX-489.0%

DNA-2685.0%

ROIC (TTM)

CYRX-543.0%

DNA-6021.0%

Cash

CYRX$269M

DNA$85M

Debt

CYRX$188M

DNA$0

Net Cash/Debt

CYRX$81M

DNA$85M

Current Ratio (TTM)

CYRX2.08x

DNA4.57x

Quick Ratio (TTM)

CYRX1.96x

DNA4.37x

Debt/Equity (TTM)

CYRX0.38x

DNA0.00x

Debt/Assets (TTM)

CYRX0.0%

DNA0.0%

Interest Coverage (TTM)

CYRXN/A

DNAN/A

Net Debt/EBITDA (TTM)

CYRX0.00x

DNA0.00x

Beta

CYRX1.88

DNA1.69

52W Performance

CYRX72.5%

DNA-19.2%

YTD Performance

CYRX81.5%

DNA49.4%

% from 52W High

CYRX-5.5%

DNA-28.6%

% from 52W Low

CYRX128.0%

DNA142.1%

Asset Turnover (TTM)

CYRX0.24x

DNA0.10x

FCF Yield (TTM)

CYRX-2.4%

DNA-21.6%

Earnings Yield (TTM)

CYRX-5.2%

DNA-35.9%

Dividend Yield (TTM)

CYRXN/A

DNAN/A

Rule of 40

CYRX-19.5

DNA-207.8

EV/GP/RG

CYRX0.63

DNA0.42

Ticker research

View CYRX research View DNA research

Metric	CYRX Cryoport Inc	DNA Ginkgo Bioworks Holdings Inc
Market & Valuation
Market Cap	$874M	$810M
Enterprise Value	$793M	$726M
Price	$17.35	$13.00
P/E Ratio	N/A	N/A
P/S Ratio	4.69x	7.24x
EV/Sales	4.25x	6.49x
EV/EBITDA	1,004.45x	0.00x
P/B Ratio	1.80x	1.98x
P/FCF Ratio	N/A	N/A
EV/FCF	-37.15x	-4.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.18x	N/A
Revenue & Growth
Revenue (TTM)	$186M	$112M
Revenue Growth (YoY)	-8.0%	-51.5%
Forward Rev Growth	8.9%	13.4%
Profitability
Gross Margin (TTM)	47.1%	77.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7.4%	-210.7%
Net Margin (TTM)	-24.3%	-260.0%
FCF Margin (TTM)	-11.4%	-156.3%
Net Income (TTM)	$-45M	$-291M
FCF (TTM)	$-21M	$-175M
EPS (TTM)	-$0.90	-$4.68
ROE (TTM)	-747.0%	-6021.0%
ROA (TTM)	-489.0%	-2685.0%
ROIC (TTM)	-543.0%	-6021.0%
Financial Health
Cash	$269M	$85M
Debt	$188M	$0
Net Cash/Debt	$81M	$85M
Current Ratio (TTM)	2.08x	4.57x
Quick Ratio (TTM)	1.96x	4.37x
Debt/Equity (TTM)	0.38x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	1.69
52W Performance	72.5%	-19.2%
YTD Performance	81.5%	49.4%
% from 52W High	-5.5%	-28.6%
% from 52W Low	128.0%	142.1%
Efficiency & Yields
Asset Turnover (TTM)	0.24x	0.10x
FCF Yield (TTM)	-2.4%	-21.6%
Earnings Yield (TTM)	-5.2%	-35.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-19.5	-207.8
EV/GP/RG	0.63	0.42
Ticker research	View CYRX research	View DNA research